The Vif Protein of HIV Triggers Degradation of the Human Antiretroviral DNA Deaminase APOBEC3G

Current Biology

Volumn 13, Issue 22, 2003, Pages 2009-2013

  Conticello, Silvestro G ^a   Harris, Reuben S ^a,b   Neuberger, Michael S ^a  

^a MRC LABORATORY OF MOLECULAR BIOLOGY   (United Kingdom)

^b UNIVERSITY OF MINNESOTA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

HUMAN IMMUNODEFICIENCY VIRUS;

EID: 0242709301     PISSN: 09609822     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cub.2003.10.034     Document Type: Article

References (21)

1. Sheehy, A.M., Gaddis, N.C., Choi, J.D., and Malim, M.H. (2002). Isolation of a human gene that inhibits HIV-1 infection and is suppressed by the viral Vif protein. Nature 418, 646-650.
2. Harris, R.S., Bishop, K.N., Sheehy, A.M., Craig, H.M., Petersen-Mahrt, S.K., Watt, I.N., Neuberger, M.S., and Malim, M.H. (2003). DNA deamination mediates innate immunity to retroviral infection. Cell 113, 803-809.
3. Mangeat, B., Turelli, P., Caron, G., Friedli, M., Perrin, L., and Trono, D. (2003). Broad antiretroviral defence by human APOBEC3G through lethal editing of nascent reverse transcripts. Nature 424, 99-103.
4. Zhang, H., Yang, B., Pomerantz, R.J., Zhang, C., Arunachalam, S.C., and Gao, L. (2003). The cytidine deaminase CEM15 induces hypermutation in newly synthesized HIV-1 DNA. Nature 424, 94-98.
5. Mariani, R., Chen, D., Schrofelbauer, B., Navarro, F., Konig, R., Bollman, B., Munk, C., Nymark-McMahon, H., and Landau, N.R. (2003). Species-specific exclusion of APOBEC3G from HIV-1 virions by Vif. Cell 114, 21-31.
6. Fisher, A.G., Ensoli, B., Ivanoff, L., Chamberlain, M., Petteway, S., Ratner, L., Gallo, R.C., and Wong-Staal, F. (1987). The sor gene of HIV-1 is required for efficient virus transmission in vitro. Science 237, 888-893.
7. Strebel, K., Daugherty, D., Clouse, K., Cohen, D., Folks, T., and Martin, M.A. (1987). The HIV 'A' (sor) gene product is essential for virus infectivity. Nature 328, 728-730.
8. Gabuzda, D.H., Lawrence, K., Langhoff, E., Terwilliger, E., Dorfman, T., Haseltine, W.A., and Sodroski, J. (1992). Role of vif in replication of human immunodeficiency virus type 1 in CD4+ T lymphocytes. J. Virol. 66, 6489-6495.
9. von Schwedler, U., Song, J., Aiken, C., and Trono, D. (1993). Vif is crucial for human immunodeficiency virus type 1 proviral DNA synthesis in infected cells. J. Virol. 67, 4945-4955.
10. Madani, N., and Kabat, D. (1998). An endogenous inhibitor of human immunodeficiency virus in human lymphocytes is overcome by the viral Vif protein. J. Virol. 72, 10251-10255.
11. Simon, J.H., Gaddis, N.C., Fouchier, R.A., and Malim, M.H. (1998). Evidence for a newly discovered cellular anti-HIV-1 phenotype. Nat. Med. 4, 1397-1400.
12. Mimnaugh, E.G., Bonvini, P., and Neckers, L. (1999). The measurement of ubiquitin and ubiquitinated proteins. Electrophoresis 20, 418-428.
13. Jarmuz, A., Chester, A., Bayliss, J., Gisbourne, J., Dunham, I., Scott, J., and Navaratnam, N. (2002). An anthropoid-specific locus of orphan C to U RNA-editing enzymes on chromosome 22. Genomics 79, 285-296.
14. Dettenhofer, M., Cen, S., Carlson, B.A., Kleiman, L., and Yu, X.F. (2000). Association of human immunodeficiency virus type 1 Vif with RNA and its role in reverse transcription. J. Virol. 74, 8938-8945.
15. Zhang, H., Pomerantz, R.J., Dornadula, G., and Sun, Y. (2000). Human immunodeficiency virus type 1 Vif protein is an integral component of an mRNP complex of viral RNA and could be involved in the viral RNA folding and packaging process. J. Virol. 74, 8252-8261.
16. Khan, M.A., Aberham, C., Kao, S., Akari, H., Gorelick, R., Bour, S., and Strebel, K. (2001). Human immunodeficiency virus type 1 Vif protein is packaged into the nucleoprotein complex through an interaction with viral genomic RNA. J. Virol. 75, 7252-7265.
17. Harris, R.S., Sheehy, A.M., Craig, H.M., Malim, M.H., and Neuberger, M.S. (2003). DNA deamination: not just a trigger for antibody diversification but also a mechanism for defense against retroviruses. Nat. Immunol. 4, 641-643.
18. Shindo, K., Takaori-Kondo, A., Kobayashi, M., Abudu, A., Fukunaga, K., and Uchiyama, T. (2003). The enzymatic activity of CEM15/Apobec-3G is essential for the regulation of the infectivity of HIV-1 Virion, but not a sole determinant of its antiviral activity. J. Biol. Chem., in press Published online September 11, 2003. 10.1074/jbc.C300376200.
19. Stopak, K., de Noronha, C., Yonemoto, W., and Greene, W.C. (2003). HIV-1 Vif blocks the antiviral activity of APOBEC3G by impairing both its translation and intracellular stability. Mol. Cell 12, 591-601.
20. Sheehy, A.M., Gaddis, N.C., and Malim, M.H. (2003).The antiretroviral enzyme APOBEC3G is degraded by the proteasome in response to HIV-1 Vif. Nat. Med., in press Published online October 5, 2003. 10.1038/nm945.
21. Marin, M., Rose, K.M., Kozak, S.L., and Kabat, D. (2003). HIV-cd1 Vif protein binds the editing enzyme APOBEC3G and induces its degradation. Nat. Med., in press Published online October 5, 2003. 10.1038/nm946.